Trial intelligence / Profile preview

Preoperative Radio-Chemotherapy With or Without Postoperative Chemotherapy in Rectal Cancer

NCT00002896Phase 3Unknown

Sponsor
European Institute of Oncology
Start
Sep 1993
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 3, randomised, open-label trial of fluorouracil and folinic acid in rectal cancer (2 arms), sponsored by European Institute of Oncology. Primary endpoints: Local Recurrence Rate, Cost-Benefit Ratio and 1 more. Status: unknown.

02

Drugs

fluorouracilfolinic acid
03

Conditions

rectal cancer

Beyond the preview

Go deeper on NCT00002896.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00002896.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call